Pleased to be at American Progress today to hear a critical conversation with Secretary Xavier Becerra on lowering prescription drug costs to advance health equity

The World’s best-selling drug, Humira, costs five times more in the U.S. than Europe. Drug companies like AbbVie exploit U.S. patent laws to keep competitors’ less expensive versions off the market. Visit PatientsPushForCompetition.org to learn more.

🆕 Too many patients, like Rose, are struggling to afford the prescription drugs they need. Read Rose’s blog for P4ADNOW here: patientsforaffordabledrugsnow.org/2024/03/12/ros…

📢 Happening now, tune in! 📢

Shocking but unsurprising. When drug companies like Harrow raise list prices, in this case from $161 per unit to a staggering $944, it puts drugs further out of reach of the patients who need them. statnews.com/pharmalot/2024…

.Vertex Pharmaceuticals CEO received a staggering $20.6 million in 2023 – a 30% increase. Meanwhile, the price of their #CysticFibrosis drug Trikafta remains out of reach for too many patients because of the cost. Once again, patients suffer while pharma profits. fiercepharma.com/pharma/vertex-…

P4ADNOW featured patient advocate Sheldon shared his story about the high price of Xarelto and Brilinta before introducing President Biden. If you struggle to afford your medications, share your story: patientsforaffordabledrugsnow.org/share-your-sto…

This Week in Drug Pricing: Patient advocate introduces POTUS, P4AD launches new tool to defend Medicare negotiations, and how the Inflation Reduction Act is lowering drug costs for women. Learn more in our Week In Review: patientsforaffordabledrugsnow.org/2024/04/05/thi…

'Just like so many others around the world, our government should be able to negotiate drug prices with all companies. That would help make life-saving drugs available to citizens” John Lauerman for Bloomberg Read more ⬇️ bloomberg.com/news/newslette…

“For too long, inhaler manufacturers have prioritized profits over patients leaving people struggling to afford the very medications they need to survive” said P4ADNOW patient advocate Kris Garcia while introducing POTUS today. And he's right. It's time to put patients first. 💯

Women are disproportionately harmed by high drug prices, especially women of color. Yesterday we were pleased to join HHS.gov and allies to learn about how the new drug law is already having a positive impact on women’s health and well-being. #inflationreductionact

👏Louder for the people in the back!👏 Big Pharma abuses the patent system to keep drug prices high while patients struggle to afford the prescriptions they need.

.HHS_ASPE announces new research on the effects of Medicare negotiation which shows that, thanks to the redesign of the Medicare Part D benefit by the Inflation Reduction Act, about 857,000 women on Medicare are projected to save $1,000 or more in 2025. hhs.gov/about/news/202…

Don’t be FOOLED by Big Pharma lies! Drug companies say that lowering prices will impact innovation, but we know it isn’t true – R&D costs have no direct correlation to drug prices. Drug companies simply set prices as high as they can. Keep fighting for lower-cost drugs with us.